WORCESTER, Mass., Oct. 26, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has made five poster presentations at the 11th Annual Canadian Diabetes Association/Canadian Society of Endocrinology and Metabolism Professional Conference and Annual Meeting (CDA/CSEM) (www.diabetes.ca) in Vancouver, British Columbia, October 24-27, 2007, and three poster presentations at the 7th Annual Diabetes Technology Meeting (www.diabetestechnology.org) in San Francisco, California, October 25-27.
